基本信息
views: 223
Career Trajectory
Bio
He is a renowned physician-scientist whose work focuses on the characterization of signaling pathways altered in primary brain tumors and on early phase clinical trials with novel drugs targeting these pathways. He has made significant contributions to our understanding of the epidermal growth factor receptor in glioblastoma, the isocitrate dehydrogenase mutation in low‐grade gliomas, and the B cell receptor signaling axis in central nervous system lymphoma. More recently, Dr. Mellinghoff expanded his work to the development of biomarkers, such as cell‐free DNA in cerebrospinal fluid and various imaging approaches.
Research Interests
Papers共 142 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of Clinical Oncologyno. 16_suppl (2024): 2005-2005
CLINICAL CANCER RESEARCHno. 3 (2024): 639-639
John Fortunato, Adam Newton,Ashley Gonzalez,Igor Gavrilovic,Alexandra Miller,Christian Grommes,Andrew Lin,Elena Pentsova,Ingo Mellinghoff,Thomas Kaley,Lauren Schaff
NEURO-ONCOLOGYno. Supplement_5 (2023): v61-v61
Neuro-Oncologyno. Supplement_5 (2023): v76-v77
Lauren Schaff, John Fortunato,Christian Grommes,Igor T. Gavrilovic,Andrew Lin,Elena Pentsova, Alex Miller, Adam Newton,Ashley Gonzalez,Ingo K. Mellinghoff,Thomas Joseph Kaley
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): TPS2087-TPS2087
Patrick Y. Wen,Katherine B. Peters,Macarena de la Fuente,Ingo K. Mellinghoff,Isabel Arrillaga‐Romany,Priya Kumthekar,Jennifer Clarke,Vinay K. Puduvalli,John de Groot, Xiangmin Zhang,Michael Chisamore, Michelle L. Abshire,
Neuro-oncologyno. Supplement_5 (2023): v64-v64
Neuro-oncologyno. Supplement_2 (2023): ii79-ii80
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn